These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin. Gordinier ME; Dizon DS; Fleming EL; Weitzen S; Schwartz J; Parker LP; Granai CO Gynecol Oncol; 2006 Oct; 103(1):72-4. PubMed ID: 16494932 [TBL] [Abstract][Full Text] [Related]
8. Distal phalange necrosis: a severe manifestation of palmar plantar erythrodysesthesia. Palaia I; Angioli R; Bellati F; Basile S; Rabitti C; Panici PB Am J Obstet Gynecol; 2006 Oct; 195(4):e1-2. PubMed ID: 16875651 [TBL] [Abstract][Full Text] [Related]
9. Pyridoxine as prophylactic therapy for palmar-plantar erythrodysesthesia associated with administration of pegylated liposomal doxorubicin (caelyx): a single-center experience. Rossi D; Catalano G Oncology; 2007; 73(3-4):277-8. PubMed ID: 18424894 [No Abstract] [Full Text] [Related]
10. Grade 3 liposomal-doxorubicin-induced skin toxicity in a patient following complete resolution of moderately severe sunburn. Markman M; Kulp B; Peterson G Gynecol Oncol; 2004 Aug; 94(2):578-80. PubMed ID: 15297208 [TBL] [Abstract][Full Text] [Related]
11. Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicin. Miolo G; Baldo P; Bidoli E; Lombardi D; Scalone S; Sorio R; Veronesi A Tumori; 2009; 95(6):687-90. PubMed ID: 20210230 [TBL] [Abstract][Full Text] [Related]
17. A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline. Hong RL; Lin CH; Chao TY; Kao WY; Wang CH; Hsieh RK; Hwang WS Cancer Chemother Pharmacol; 2008 Apr; 61(5):847-53. PubMed ID: 17609947 [TBL] [Abstract][Full Text] [Related]
18. "Skin problems associated with pegylated liposomal doxorubicin -- more than palmoplantar erythrodysesthesia syndrome". Von Moos R; Cathomas R Eur J Dermatol; 2009; 19(3):264-5. PubMed ID: 19213658 [No Abstract] [Full Text] [Related]
19. Pegylated liposomal doxorubicin-induced palmar-plantar erythrodysestesia in multiple uncommon sites. Corazza M; Minghetti S; Zauli S; Ricci M; Borghi A; Virgili A Eur J Dermatol; 2011; 21(3):433-4. PubMed ID: 21515437 [No Abstract] [Full Text] [Related]
20. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Lopez AM; Wallace L; Dorr RT; Koff M; Hersh EM; Alberts DS Cancer Chemother Pharmacol; 1999; 44(4):303-6. PubMed ID: 10447577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]